Shilpa Medicare Ltd.

814.95-0.73%

2026-08-21

vbshilpa.comBSE: 530549NSE: SHILPAMED
Market Cap₹ 15,789 Cr.
Current Price₹ 821
High / Low₹ 825 / 260
Stock P/E0.0
Book Value₹ 142
Price to Book2.51
Dividend Yield0.07 %
ROCE5.7 %
ROE5.0 %
Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2021 • Bulk Drugs and Intermediates: 99.3% • Power: 0.6% • Others: 0.1%

PROS

  • Company is almost debt free
  • Latest quarter profit grew 213.6% YoY, showing strong momentum
  • Operating margins have improved to 19.1% from 9.9%
  • Company has delivered good sales growth of 18.4% CAGR over last 5 years
  • Company comfortably covers its interest (15.8x coverage)

CONS

  • A large part of profit comes from other income (53.9% of PBT)
  • Company has a low return on capital employed of 4.1%
  • Company has a low return on equity of 3.0% over last 3 years
  • Promoter holding has decreased over last 2 years: -4.3pp
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.22x)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.SUNPHARMA1898.0037.65455393.780.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB8525.0077.37226311.960.35902.0065.503080.0027.8021.5140.75
3.TORNTPHARM5013.0087.43190678.410.76566.003.284921.0057.3219.2733.81
4.CIPLA1416.0033.94114392.010.92785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1105.0024.42110224.170.09990.20-34.908017.0023.9721.3924.54
6.LUPIN2220.0018.36101506.150.811416.9816.018276.8934.2828.8629.59
7.MANKIND2391.0048.3498747.340.04574.0929.124030.5912.8913.2426.30
8.DRREDDY1171.0030.3397740.540.68435.60-69.108099.80-5.2113.7510.63
9.LAURUSLABS1807.0089.3097634.420.113620.702139.4220263.101191.0018.2031.50
10.AUROPHARMA1615.1525.0392932.160.251032.0325.229150.3517.4412.7620.54
11.BIOCON414.30136.3267518.230.12136.8053.364336.0010.893.2619.54
12.SHILPAMED807.3053.1115789.320.071008.802051.604657.801348.9511.4330.53
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023
84
68
Operating Profit
OPM %
Other Income
21
Interest
7
Depreciation
12
11
Tax %
26.58%
Net Profit
8
1
Equity Capital
9
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
9
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
75
67
Operating Profit
OPM %
Other Income
23
Interest
5
Depreciation
13
12
Tax %
44.92%
Net Profit
7
1
Equity Capital
9
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
9
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
64
67
Operating Profit
OPM %
Other Income
22
Interest
3
Depreciation
12
4
Tax %
30.95%
Net Profit
3
0
Equity Capital
9
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
9
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
87
80
Operating Profit
OPM %
Other Income
23
Interest
3
Depreciation
12
11
Tax %
14.79%
Net Profit
10
1
Equity Capital
9
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
9
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
96
73
Operating Profit
OPM %
Other Income
31
Interest
2
Depreciation
12
40
Tax %
30.67%
Net Profit
28
3
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
130
87
Operating Profit
OPM %
Other Income
21
Interest
1
Depreciation
12
50
Tax %
40.20%
Net Profit
30
2
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
125
103
Operating Profit
OPM %
Other Income
16
Interest
1
Depreciation
12
25
Tax %
37.05%
Net Profit
16
1
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
126
88
Operating Profit
OPM %
Other Income
11
Interest
2
Depreciation
12
-10
Tax %
43.19%
Net Profit
-6
-0
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
92
75
Operating Profit
OPM %
Other Income
18
Interest
2
Depreciation
13
15
Tax %
-39.99%
Net Profit
21
2
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
135
96
Operating Profit
OPM %
Other Income
17
Interest
2
Depreciation
13
39
Tax %
20.81%
Net Profit
31
2
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
10
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
166
135
Operating Profit
OPM %
Other Income
11
Interest
3
Depreciation
14
24
Tax %
33.00%
Net Profit
16
1
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
201
141
Operating Profit
OPM %
Other Income
7
Interest
3
Depreciation
14
78
Tax %
9.05%
Net Profit
71
4
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
20
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
1,890
1,510
Operating Profit
OPM %
Other Income
96
Interest
25
Depreciation
155
511
Tax %
-27.14%
Net Profit
649
3
Equity Capital
196
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
196
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
734
561
Operating Profit
203
OPM %
28
Other Income
30
Interest
3
Depreciation
27
169
Tax %
24
Net Profit
127
EPS
16
Dividend Payout %
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Mar 2018
741
573
Operating Profit
202
OPM %
27
Other Income
35
Interest
2
Depreciation
33
167
Tax %
20
Net Profit
133
EPS
17
Dividend Payout %
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Mar 2019
664
477
Operating Profit
204
OPM %
31
Other Income
17
Interest
3
Depreciation
34
173
Tax %
22
Net Profit
136
EPS
-1
Dividend Payout %
6
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Mar 2020
806
568
Operating Profit
256
OPM %
32
Other Income
18
Interest
4
Depreciation
35
212
Tax %
21
Net Profit
168
EPS
24
Dividend Payout %
5
Minority Interest
0
Share of Associates
0
Adjusted EPS
10
Minority Interest
0
Share of Associates
0
Adjusted EPS
10
Mar 2021
257
229
Operating Profit
66
OPM %
26
Other Income
37
Interest
6
Depreciation
22
90
Tax %
28
Net Profit
65
EPS
23
Dividend Payout %
14
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Minority Interest
0
Share of Associates
0
Adjusted EPS
4
Mar 2022
357
346
Operating Profit
63
OPM %
18
Other Income
52
Interest
9
Depreciation
35
27
Tax %
27
Net Profit
20
EPS
17
Dividend Payout %
47
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Minority Interest
0
Share of Associates
0
Adjusted EPS
1
Mar 2023
248
303
Operating Profit
25
OPM %
10
Other Income
80
Interest
21
Depreciation
47
-58
Tax %
15
Net Profit
-49
EPS
7
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
-3
Minority Interest
0
Share of Associates
0
Adjusted EPS
-3
Mar 2024
310
288
Operating Profit
115
OPM %
37
Other Income
94
Interest
17
Depreciation
50
38
Tax %
29
Net Profit
27
EPS
3
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Minority Interest
0
Share of Associates
0
Adjusted EPS
2
Mar 2025
477
351
Operating Profit
206
OPM %
43
Other Income
79
Interest
6
Depreciation
49
105
Tax %
36
Net Profit
68
EPS
7
Dividend Payout %
14
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Minority Interest
0
Share of Associates
0
Adjusted EPS
3
Mar 2026
597
483
Operating Profit
194
OPM %
32
Other Income
80
Interest
10
Depreciation
55
148
Tax %
10
Net Profit
133
EPS
7
Dividend Payout %
9
Minority Interest
0
Share of Associates
0
Adjusted EPS
7
Minority Interest
0
Share of Associates
0
Adjusted EPS
7
TTM
2,392
1,882
Operating Profit
OPM %
Other Income
131
Interest
33
Depreciation
196
651
Tax %
-18
Net Profit
767
EPS
Dividend Payout %
Minority Interest
0
Share of Associates
0
Adjusted EPS
Minority Interest
0
Share of Associates
0
Adjusted EPS

COMPOUNDED SALES GROWTH

10 Years:
-1%
5 Years:
18%
3 Years:
34%

COMPOUNDED PROFIT GROWTH

10 Years:
2%
5 Years:
15%
3 Years:

STOCK PRICE CAGR

10 Years:
11%
5 Years:
23%
3 Years:
65%
1 Year:
92%

RETURN ON EQUITY

10 Years:
6%
5 Years:
2%
3 Years:
3%
Last Year:
5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2025

Oct 3

1:1

Quarterly Results & Bonus issue

Mar 2017
Equity Capital
8
1,022
88
Trade Payables
104
269
Total Liabilities
1,490
449
Capital Work in Progress
88
326
175
0
Cash & Bank
93
359
Total Assets
1,490
Total Debt
237
Net Working Capital
485
Contingent Liabilities
132
Book Value per Share
128.50
Face Value
1.00
Total Debt
237
Net Working Capital
485
Contingent Liabilities
132
Book Value per Share
128.50
Face Value
1.00
Mar 2018
Equity Capital
8
1,149
93
Trade Payables
99
198
Total Liabilities
1,547
489
Capital Work in Progress
131
231
168
0
Cash & Bank
73
456
Total Assets
1,547
Total Debt
186
Net Working Capital
402
Contingent Liabilities
172
Book Value per Share
141.91
Face Value
1.00
Total Debt
186
Net Working Capital
402
Contingent Liabilities
172
Book Value per Share
141.91
Face Value
1.00
Mar 2019
Equity Capital
8
1,273
79
Trade Payables
71
237
Total Liabilities
1,668
511
Capital Work in Progress
285
97
177
0
Cash & Bank
91
508
Total Assets
1,668
Total Debt
186
Net Working Capital
291
Contingent Liabilities
165
Book Value per Share
157.19
Face Value
1.00
Total Debt
186
Net Working Capital
291
Contingent Liabilities
165
Book Value per Share
157.19
Face Value
1.00
Mar 2020
Equity Capital
8
1,445
156
Trade Payables
77
335
Total Liabilities
2,021
517
Capital Work in Progress
244
101
206
0
Cash & Bank
28
924
Total Assets
2,021
Total Debt
380
Net Working Capital
548
Contingent Liabilities
41
Book Value per Share
178.27
Face Value
1.00
Total Debt
380
Net Working Capital
548
Contingent Liabilities
41
Book Value per Share
178.27
Face Value
1.00
Mar 2021
Equity Capital
8
1,630
242
Trade Payables
57
581
Total Liabilities
2,517
641
Capital Work in Progress
297
219
299
0
Cash & Bank
115
946
Total Assets
2,517
Total Debt
653
Net Working Capital
306
Contingent Liabilities
208
Book Value per Share
200.89
Face Value
1.00
Total Debt
653
Net Working Capital
306
Contingent Liabilities
208
Book Value per Share
200.89
Face Value
1.00
Mar 2022
Equity Capital
9
2,057
40
Trade Payables
24
767
Total Liabilities
2,896
566
Capital Work in Progress
53
237
102
0
Cash & Bank
16
1,923
Total Assets
2,896
Total Debt
194
Net Working Capital
148
Contingent Liabilities
374
Book Value per Share
237.97
Face Value
1.00
Total Debt
194
Net Working Capital
148
Contingent Liabilities
374
Book Value per Share
237.97
Face Value
1.00
Mar 2023
Equity Capital
9
2,109
126
Trade Payables
32
243
Total Liabilities
2,519
609
Capital Work in Progress
42
244
95
0
Cash & Bank
5
1,525
Total Assets
2,519
Total Debt
287
Net Working Capital
394
Contingent Liabilities
510
Book Value per Share
243.96
Face Value
1.00
Total Debt
287
Net Working Capital
394
Contingent Liabilities
510
Book Value per Share
243.96
Face Value
1.00
Mar 2024
Equity Capital
9
2,134
113
Trade Payables
53
111
Total Liabilities
2,419
586
Capital Work in Progress
10
246
112
144
Cash & Bank
4
1,316
Total Assets
2,419
Total Debt
143
Net Working Capital
164
Contingent Liabilities
655
Book Value per Share
246.85
Face Value
1.00
Total Debt
143
Net Working Capital
164
Contingent Liabilities
655
Book Value per Share
246.85
Face Value
1.00
Mar 2025
Equity Capital
10
2,637
82
Trade Payables
40
169
Total Liabilities
2,938
570
Capital Work in Progress
39
1,236
149
177
Cash & Bank
4
764
Total Assets
2,938
Total Debt
97
Net Working Capital
229
Contingent Liabilities
503
Book Value per Share
270.65
Face Value
1.00
Total Debt
97
Net Working Capital
229
Contingent Liabilities
503
Book Value per Share
270.65
Face Value
1.00
Mar 2026
Equity Capital
20
2,694
116
Trade Payables
85
114
Total Liabilities
3,029
639
Capital Work in Progress
37
1,223
175
223
Cash & Bank
11
722
Total Assets
3,029
Total Debt
130
Net Working Capital
250
Contingent Liabilities
235
Book Value per Share
138.72
Face Value
1.00
Total Debt
130
Net Working Capital
250
Contingent Liabilities
235
Book Value per Share
138.72
Face Value
1.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
50
Cash from Investing
-275
Cash from Financing
315
91
Free Cash Flow
-73
OCF / Net Profit
0.40
Cumulative 5-Year FCF
0
OCF / Net Profit
0.40
Cumulative 5-Year FCF
0
Mar 2018
54
Cash from Investing
-13
Cash from Financing
-61
-20
Free Cash Flow
-61
OCF / Net Profit
0.41
Cumulative 5-Year FCF
0
OCF / Net Profit
0.41
Cumulative 5-Year FCF
0
Mar 2019
164
Cash from Investing
-215
Cash from Financing
8
-42
Free Cash Flow
-46
OCF / Net Profit
1.21
Cumulative 5-Year FCF
0
OCF / Net Profit
1.21
Cumulative 5-Year FCF
0
Mar 2020
130
Cash from Investing
-295
Cash from Financing
170
5
Free Cash Flow
130
OCF / Net Profit
0.77
Cumulative 5-Year FCF
0
OCF / Net Profit
0.77
Cumulative 5-Year FCF
0
Mar 2021
70
Cash from Investing
-238
Cash from Financing
256
87
Free Cash Flow
-146
OCF / Net Profit
1.07
Cumulative 5-Year FCF
-197
OCF / Net Profit
1.07
Cumulative 5-Year FCF
-197
Mar 2022
174
Cash from Investing
-379
Cash from Financing
97
-108
Free Cash Flow
174
OCF / Net Profit
8.63
Cumulative 5-Year FCF
50
OCF / Net Profit
8.63
Cumulative 5-Year FCF
50
Mar 2023
2
Cash from Investing
-95
Cash from Financing
88
-5
Free Cash Flow
-76
OCF / Net Profit
-0.04
Cumulative 5-Year FCF
35
OCF / Net Profit
-0.04
Cumulative 5-Year FCF
35
Mar 2024
10
Cash from Investing
156
Cash from Financing
-163
2
Free Cash Flow
10
OCF / Net Profit
0.35
Cumulative 5-Year FCF
91
OCF / Net Profit
0.35
Cumulative 5-Year FCF
91
Mar 2025
-19
Cash from Investing
-433
Cash from Financing
450
-2
Free Cash Flow
-73
OCF / Net Profit
-0.28
Cumulative 5-Year FCF
-112
OCF / Net Profit
-0.28
Cumulative 5-Year FCF
-112
Mar 2026
60
Cash from Investing
-67
Cash from Financing
14
7
Free Cash Flow
-73
OCF / Net Profit
0.45
Cumulative 5-Year FCF
-39
OCF / Net Profit
0.45
Cumulative 5-Year FCF
-39

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017
EPS (₹)
15.91
Book Value (₹)
128.50
Dividend per Share (₹)
0.60
Cash EPS (₹)
9.62
Operating Margin %
27.45%
Net Margin %
17.27%
ROE %
15.05%
ROCE %
16.98%
10.53%
Debtor Days
69
Inventory Days
74
Payable Days
101
42
Debt to Equity (x)
0.23x
Interest Coverage (x)
61.31x
3.21x
Revenue Growth %
8.56%
Operating Profit Growth %
15.35%
Net Profit Growth %
12.92%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
16.34
Book Value (₹)
141.91
Dividend per Share (₹)
0.70
Cash EPS (₹)
10.18
Operating Margin %
27.20%
Net Margin %
17.91%
ROE %
12.19%
ROCE %
13.00%
8.77%
Debtor Days
94
Inventory Days
84
Payable Days
106
72
Debt to Equity (x)
0.16x
Interest Coverage (x)
79.92x
2.60x
Revenue Growth %
1.04%
Operating Profit Growth %
-0.07%
Net Profit Growth %
4.54%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
16.65
Book Value (₹)
157.19
Dividend per Share (₹)
1.00
Cash EPS (₹)
10.41
Operating Margin %
30.74%
Net Margin %
20.45%
ROE %
11.13%
ROCE %
12.54%
8.44%
Debtor Days
110
Inventory Days
95
Payable Days
135
69
Debt to Equity (x)
0.15x
Interest Coverage (x)
63.10x
2.27x
Revenue Growth %
-10.44%
Operating Profit Growth %
0.84%
Net Profit Growth %
1.88%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
20.63
Book Value (₹)
178.27
Dividend per Share (₹)
1.10
Cash EPS (₹)
12.46
Operating Margin %
31.78%
Net Margin %
20.87%
ROE %
12.30%
ROCE %
13.13%
9.12%
Debtor Days
92
Inventory Days
87
Payable Days
105
75
Debt to Equity (x)
0.26x
Interest Coverage (x)
50.05x
2.52x
Revenue Growth %
21.40%
Operating Profit Growth %
25.52%
Net Profit Growth %
23.90%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
7.98
Book Value (₹)
200.89
Dividend per Share (₹)
1.10
Cash EPS (₹)
5.36
Operating Margin %
25.53%
Net Margin %
25.32%
ROE %
4.21%
ROCE %
4.67%
2.87%
Debtor Days
316
Inventory Days
359
Payable Days
479
195
Debt to Equity (x)
0.40x
Interest Coverage (x)
15.85x
1.65x
Revenue Growth %
-68.11%
Operating Profit Growth %
-74.39%
Net Profit Growth %
-61.30%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
2.32
Book Value (₹)
237.97
Dividend per Share (₹)
1.10
Cash EPS (₹)
3.17
Operating Margin %
17.52%
Net Margin %
5.65%
ROE %
1.09%
ROCE %
1.61%
0.74%
Debtor Days
164
Inventory Days
205
Payable Days
218
151
Debt to Equity (x)
0.09x
Interest Coverage (x)
4.04x
1.91x
Revenue Growth %
38.86%
Operating Profit Growth %
-4.68%
Net Profit Growth %
-69.03%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
-5.70
Book Value (₹)
243.96
Dividend per Share (₹)
0.00
Cash EPS (₹)
-0.17
Operating Margin %
9.95%
Net Margin %
-19.98%
ROE %
-2.37%
ROCE %
-1.61%
-1.83%
Debtor Days
158
Inventory Days
145
Payable Days
139
164
Debt to Equity (x)
0.14x
Interest Coverage (x)
-1.80x
2.62x
Revenue Growth %
-30.61%
Operating Profit Growth %
-60.60%
Net Profit Growth %
-345.47%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
3.10
Book Value (₹)
246.85
Dividend per Share (₹)
0.00
Cash EPS (₹)
4.41
Operating Margin %
6.93%
Net Margin %
8.70%
ROE %
1.26%
ROCE %
2.36%
1.09%
Debtor Days
151
Inventory Days
122
Payable Days
194
78
Debt to Equity (x)
0.07x
Interest Coverage (x)
3.21x
1.77x
Revenue Growth %
25.06%
Operating Profit Growth %
368.32%
Net Profit Growth %
154.44%
154.44%
P/E (x)
74.33x
P/B (x)
1.87x
Dividend Yield %
0.00%
35.90x
Mar 2025
EPS (₹)
6.94
Book Value (₹)
270.65
Dividend per Share (₹)
1.00
Cash EPS (₹)
5.97
Operating Margin %
26.58%
Net Margin %
14.22%
ROE %
2.84%
ROCE %
4.42%
2.54%
Debtor Days
123
Inventory Days
100
Payable Days
153
69
Debt to Equity (x)
0.04x
Interest Coverage (x)
18.94x
2.01x
Revenue Growth %
54.11%
Operating Profit Growth %
78.32%
Net Profit Growth %
152.06%
123.72%
P/E (x)
47.75x
P/B (x)
2.45x
Dividend Yield %
0.15%
31.95x
Mar 2026
EPS (₹)
6.80
Book Value (₹)
138.72
Dividend per Share (₹)
0.60
Cash EPS (₹)
9.62
Operating Margin %
19.10%
Net Margin %
22.27%
ROE %
4.96%
ROCE %
5.66%
4.46%
Debtor Days
122
Inventory Days
99
Payable Days
108
113
Debt to Equity (x)
0.05x
Interest Coverage (x)
15.75x
1.90x
Revenue Growth %
25.06%
Operating Profit Growth %
-5.80%
Net Profit Growth %
95.85%
-2.08%
P/E (x)
51.28x
P/B (x)
2.51x
Dividend Yield %
0.17%
35.79x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
44.39
9.08
7.61
Government
0.00
38.92
Sep 2024
44.33
9.59
8.18
Government
0.00
37.90
Dec 2024
44.23
9.90
8.27
Government
0.00
37.60
Mar 2025
44.23
10.97
7.55
Government
0.00
37.25
Jun 2025
44.23
11.19
7.44
Government
0.00
37.13
Sep 2025
44.23
10.92
7.65
Government
0.00
37.20
Dec 2025
40.13
10.97
8.34
Government
0.00
40.56
Mar 2026
40.13
11.08
8.58
Government
0.00
40.21
Jun 2026
40.13
11.39
8.05
Government
0.00
40.43

Documents

Announcements

  • General Updates

    2026-08-19 - Dispatch of letter to shareholders whose e-mail addresses are not registered with Company/Registrar & Transfer Agent/Depository Participants.

  • General Updates

    2026-08-18 - Shilpa Medicare Limited has informed the Exchange about Response on the news item captioned Shilpa Medicare recalls over 27k vials of chemotherapy drug in US published in the online edition of The Economic Times on August 17, 2026 Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Credit Ratings

  • Credit Rating

    2026-07-16 - Shilpa Medicare Limited has informed the Exchange about Credit Rating

  • Credit Rating

    2026-07-07 - Shilpa Medicare Limited has informed the Exchange about Credit Rating

Concalls